Japanese gaming giant Gumi and SBI will launch the crypto investment fund SBI Crypto Fund I, with a scale of approximately $18.3 million.
ChainCatcher News: According to official sources, Japanese gaming giant Gumi, through its subsidiary gC Labs, will launch the “SBI Crypto Fund I” crypto investment fund, jointly established with SBI Financial Services, on August 1. The fund size is approximately 3 billion yen (about $18.3 million), with a term of three years, structured as a private placement, and participation from multiple institutions including Daiwa Securities Group.
The fund will mainly invest in Bitcoin and mainstream altcoins, employing a portfolio of staking, rebalancing, and hedging strategies. The fund aims to serve as a bridge between the crypto asset market and Japanese enterprises, building a track record for the development of future financial products such as crypto ETFs. Currently, crypto ETFs have not yet been approved in Japan, and the launch of this fund is seen as an attempt to integrate traditional finance with digital assets.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
